Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02613689 · ClinicalTrials.gov registry record · NA

Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT02613689: Completed NA study, sponsored by Duke University.

NCT02613689 is a NA study that has completed, run by Duke University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02613689, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the feasibility, acceptability and preliminary efficacy of a Scheduled Gradual Reduction (SGR) intervention via Short Message Service (SMS) text messaging plus SMS Support Messages in decreasing smokeless tobacco use in a rural population.

Primary Outcome

Assessed via text history

Interventions

  • BEHAVIORAL Text Messages
  • BEHAVIORAL Scheduled Gradual Reduction (SGR)

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2016-02
Est. Completion 2018-12-31
Phase NA
Duke University

1,725 total trials

What the finished NCT02613689 record still lists

NCT02613689 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Text Messages is the first listed.

NCT02613689 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02613689 about?

NCT02613689 is a clinical study titled "Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention". The purpose of this study is to evaluate the feasibility, acceptability and preliminary efficacy of a Scheduled Gradual Reduction (SGR) intervention via Short Message Service (SMS) text messaging plus SMS Support Messages in decreasing smokeless tobacco use in a rural population.

What is the current status of trial NCT02613689?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2016-02. Estimated completion is 2018-12-31.

What interventions are being tested in trial NCT02613689?

The interventions under investigation include: Text Messages (BEHAVIORAL), Scheduled Gradual Reduction (SGR) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02613689?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02613689's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02613689, the US trial registry maintained by the National Library of Medicine. NCT02613689 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.